A phase Ib/IIa trial in patients with R/R CD30+ T-cell lymphoma with cutaneous presentation in 15 patients, including 5 with a PTCL variant, reported a poster at ASH 2020. The gene discussed is TNFRSF8; the disease is T-cell non-Hodgkin lymphoma.